Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...